Intech Investment Management LLC Sells 216,973 Shares of DENTSPLY SIRONA Inc. $XRAY

Intech Investment Management LLC lessened its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 81.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,005 shares of the medical instruments supplier’s stock after selling 216,973 shares during the quarter. Intech Investment Management LLC’s holdings in DENTSPLY SIRONA were worth $560,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA during the first quarter worth $26,000. Huntington National Bank grew its position in shares of DENTSPLY SIRONA by 292.9% in the 3rd quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,077 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,122 shares during the period. Farther Finance Advisors LLC increased its stake in shares of DENTSPLY SIRONA by 119.1% during the 4th quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after purchasing an additional 2,051 shares during the last quarter. Finally, Hantz Financial Services Inc. raised its holdings in shares of DENTSPLY SIRONA by 275.0% in the 4th quarter. Hantz Financial Services Inc. now owns 5,992 shares of the medical instruments supplier’s stock valued at $68,000 after purchasing an additional 4,394 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Up 2.0%

Shares of XRAY stock opened at $10.47 on Wednesday. The firm has a 50 day moving average price of $11.07 and a two-hundred day moving average price of $11.72. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52. The company has a market capitalization of $2.10 billion, a PE ratio of -3.32, a price-to-earnings-growth ratio of 1.22 and a beta of 0.89. DENTSPLY SIRONA Inc. has a 12-month low of $9.40 and a 12-month high of $17.09.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The company had revenue of $880.00 million for the quarter, compared to analyst estimates of $841.80 million. During the same quarter last year, the business earned $0.43 earnings per share. The company’s revenue was up .1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, analysts predict that DENTSPLY SIRONA Inc. will post 1.42 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on XRAY shares. Bank of America upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and raised their target price for the stock from $13.00 to $17.00 in a research note on Thursday, February 19th. Mizuho lowered their price target on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Zacks Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Barclays cut their price objective on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research report on Thursday, June 4th. Finally, Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the stock an “outperform” rating in a research report on Monday, March 2nd. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $13.55.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.